AMELUZ
Live / Registered — Registered — Section 71 accepted (as of 02 Oct 2021)
What this means for you
Registered since 10 May 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79079825
- Registration number
- 3956761
- Mark type
- Stylized text
- Filed
- 23 Dec 2009
- Published for opposition
- 22 Feb 2011
- Registered
- 10 May 2011
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; pharmaceutical preparations for skin rejuvenation; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for wound healing; pharmaceutical preparations for the treatment of acne vulgaris; pharmaceutical preparations for anti-bacterial therapy; [ sanitary preparations for medical use; fungicides, herbicides; media for bacteriological cultures; ] bacteriological preparations for medical purposes; biological preparations for medical purposes, namely, skin disorders and skin cancers; biochemical preparations for medical purposes, namely, skin disorders and skin cancers; [ enzymes for medical purposes; ] ferments for pharmaceutical purposes; [ vaccines; nutritive substances for microorganisms for medical purposes; chemical preparations for sanitary purposes; ] chemical reagants for medical purposes; [ chemical preparations for sanitary use; ]medicines for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; medicines for skin rejuvenation; medicines for the treatment of psoriasis; medicines for wound healing; medicines for the treatment of acne vulgaris; medicines for anti-bacterial therapy; medicated ointments and gels for the treatment of skin disorders and skin cancers
Owner
- Biofrontera Inc., US
- Biofrontera Pharma GmbH, 51377 Leverkusen, DE
- Biofrontera Pharma GmbH, DE
- Biofrontera Pharma GmbH, DE
Prosecution history
- 02 Apr 2026 — CHANGE OF OWNER RECEIVED FROM IB
- 19 Sept 2022 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 12 Aug 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 12 Aug 2022 — INVALIDATION PROCESSED
- 02 Jun 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 02 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 02 Oct 2021 — REGISTERED-SEC.71 ACCEPTED
- 28 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 May 2021 — TEAS SECTION 71 RECEIVED
- 10 May 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 09 Jan 2020 — INTERNATIONAL REGISTRATION RENEWED
- 10 Jun 2017 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 10 Jun 2017 — REGISTERED-SEC.71 ACCEPTED
- 05 Jun 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 May 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED